PTP Accounts Production v24.2.0.383 05723433 Board of Directors Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh057234332023-06-30057234332024-06-30057234332023-07-012024-06-30057234332022-06-30057234332022-07-012023-06-30057234332023-06-3005723433ns15:EnglandWales2023-07-012024-06-3005723433ns14:PoundSterling2023-07-012024-06-3005723433ns10:Director12023-07-012024-06-3005723433ns10:Director22023-07-012024-06-3005723433ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3005723433ns10:SmallEntities2023-07-012024-06-3005723433ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3005723433ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3005723433ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3005723433ns10:FullAccounts2023-07-012024-06-3005723433ns10:CompanySecretary12023-07-012024-06-3005723433ns10:RegisteredOffice2023-07-012024-06-3005723433ns5:CurrentFinancialInstruments2024-06-3005723433ns5:CurrentFinancialInstruments2023-06-3005723433ns5:Non-currentFinancialInstruments2024-06-3005723433ns5:Non-currentFinancialInstruments2023-06-3005723433ns5:ShareCapital2024-06-3005723433ns5:ShareCapital2023-06-3005723433ns5:RevaluationReserve2024-06-3005723433ns5:RevaluationReserve2023-06-3005723433ns5:RetainedEarningsAccumulatedLosses2024-06-3005723433ns5:RetainedEarningsAccumulatedLosses2023-06-3005723433ns5:FurnitureFittings2023-07-012024-06-3005723433ns5:ComputerEquipment2023-07-012024-06-3005723433ns5:LandBuildings2023-06-3005723433ns5:FurnitureFittings2023-06-3005723433ns5:ComputerEquipment2023-06-3005723433ns5:LandBuildings2023-07-012024-06-3005723433ns5:LandBuildings2024-06-3005723433ns5:FurnitureFittings2024-06-3005723433ns5:ComputerEquipment2024-06-3005723433ns5:LandBuildings2023-06-3005723433ns5:FurnitureFittings2023-06-3005723433ns5:ComputerEquipment2023-06-3005723433ns5:RevaluationReserve2023-06-30057234331ns10:Director12023-06-30057234331ns10:Director12022-06-30057234331ns10:Director12023-07-012024-06-30057234331ns10:Director12022-07-012023-06-30057234331ns10:Director12024-06-30057234331ns10:Director12023-06-30
REGISTERED NUMBER: 05723433 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2024

for

Continuum Healthcare Limited

Continuum Healthcare Limited (Registered number: 05723433)

Contents of the Financial Statements
for the Year Ended 30 June 2024










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Continuum Healthcare Limited

Company Information
for the Year Ended 30 June 2024







DIRECTORS: Mrs Bibi Nazeemah Patel
Mr Ashraf Patel





SECRETARY: Mrs Bibi Nazeemah Patel





REGISTERED OFFICE: 74A High Street
Wanstead
London
E11 2RJ





REGISTERED NUMBER: 05723433 (England and Wales)





ACCOUNTANTS: Ashford Associates UK Limited
Chartered Certified Accountants
74A High Street
Wanstead
London
E11 2RJ

Continuum Healthcare Limited (Registered number: 05723433)

Statement of Financial Position
30 June 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,304,645 1,308,680

CURRENT ASSETS
Cash at bank and in hand 351,003 53,789

CREDITORS
Amounts falling due within one year 5 957,452 807,439
NET CURRENT LIABILITIES (606,449 ) (753,650 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

698,196

555,030

CREDITORS
Amounts falling due after more than one year 6 (153,183 ) (208,634 )

PROVISIONS FOR LIABILITIES - (6,510 )
NET ASSETS 545,013 339,886

CAPITAL AND RESERVES
Called up share capital 100 100
Revaluation reserve 7 158,256 158,256
Retained earnings 386,657 181,530
SHAREHOLDERS' FUNDS 545,013 339,886

Continuum Healthcare Limited (Registered number: 05723433)

Statement of Financial Position - continued
30 June 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 31 March 2025 and were signed on its behalf by:




Mr Ashraf Patel - Director



Mrs Bibi Nazeemah Patel - Director


Continuum Healthcare Limited (Registered number: 05723433)

Notes to the Financial Statements
for the Year Ended 30 June 2024


1. STATUTORY INFORMATION

Continuum Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 33% on reducing balance

The building shown as asset of the company is secured by bank loan. The bank has first charge over the asset.
The Land and Building is valued at open market value for existing use basis by the director.
The Director valuation is taken and director will get professional valuation done after 3 years period.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The directors have prepared the accounts under going concern concept inspite of negative net assets position. This is due to bank loan secured as first charge on building of the company. The directors believe that the company has traded for the next 12 months without any overdraft position. The company has continuous bank and directors support.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 38 (2023 - 40 ) .

Continuum Healthcare Limited (Registered number: 05723433)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024


4. TANGIBLE FIXED ASSETS
Fixtures
Freehold and Computer
property fittings equipment Totals
£    £    £    £   
COST OR VALUATION
At 1 July 2023
and 30 June 2024 1,650,000 115,288 7,182 1,772,470
DEPRECIATION
At 1 July 2023 357,461 100,421 5,908 463,790
Charge for year - 3,717 318 4,035
At 30 June 2024 357,461 104,138 6,226 467,825
NET BOOK VALUE
At 30 June 2024 1,292,539 11,150 956 1,304,645
At 30 June 2023 1,292,539 14,867 1,274 1,308,680

Cost or valuation at 30 June 2024 is represented by:

Fixtures
Freehold and Computer
property fittings equipment Totals
£    £    £    £   
Valuation in 2024 1,650,000 115,288 7,182 1,772,470

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 52,000 52,000
Taxation and social security 80,194 (427 )
Other creditors 825,258 755,866
957,452 807,439

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 153,183 208,634

7. RESERVES
Revaluation
reserve
£   
At 1 July 2023
and 30 June 2024 158,256

Continuum Healthcare Limited (Registered number: 05723433)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024


8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 June 2024 and 30 June 2023:

2024 2023
£    £   
Mr Ashraf Patel
Balance outstanding at start of year (464,050 ) (485,096 )
Amounts advanced (68,892 ) 21,046
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (532,942 ) (464,050 )

ULTIMATE CONTROLLING PARTY

At the balance sheet date, the company was under common control of Mr A Patel and Mrs B N Patel who held 50% shares each and were the ultimate control parties.

RELATED PARTY TRANSACTIONS

As at Balance Sheet date, the Directors, Mr and Mrs Patel were owed £ 532,942 (2023:£ 464,050 ) by the company. This was interest free loan to the company.

Mr Ashraf Patel and Mrs Bibi Nazeemah Patel also own 100% shares of other associated companies, Fairlight Manor Ltd.

As at Balance sheet date, the company owed £ 278,816 (2023: £278,816) to Fairlight Manor Ltd. This was interest free loan to the company.